X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (680) 680
Book Review (83) 83
Publication (51) 51
Book Chapter (3) 3
Conference Proceeding (3) 3
Book / eBook (2) 2
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (497) 497
humans (484) 484
male (368) 368
female (330) 330
middle aged (285) 285
cardiac & cardiovascular systems (223) 223
adult (195) 195
risk factors (186) 186
aged (183) 183
atherosclerosis (182) 182
cholesterol (182) 182
abridged index medicus (171) 171
peripheral vascular disease (150) 150
cardiovascular disease (122) 122
cholesterol, ldl - blood (113) 113
cardiovascular (109) 109
statins (106) 106
hypercholesterolemia (104) 104
risk (101) 101
familial hypercholesterolemia (95) 95
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (90) 90
lipoproteins (90) 90
lipids (87) 87
cholesterol, hdl - blood (84) 84
double-blind method (82) 82
myocardial-infarction (82) 82
coronary heart disease (79) 79
genetic aspects (78) 78
hyperlipoproteinemia type ii - genetics (76) 76
mutation (75) 75
cardiovascular-disease (74) 74
treatment outcome (73) 73
coronary-heart-disease (71) 71
low density lipoproteins (70) 70
adolescent (68) 68
cardiovascular diseases (67) 67
heart-disease (65) 65
anticholesteremic agents - therapeutic use (62) 62
drug therapy (60) 60
prospective studies (60) 60
triglycerides - blood (58) 58
medicine, general & internal (57) 57
hyperlipoproteinemia type ii - drug therapy (54) 54
prevention (54) 54
research (54) 54
density-lipoprotein cholesterol (53) 53
genotype (53) 53
hematology (53) 53
low density lipoprotein (53) 53
genetics (51) 51
heterozygote (51) 51
high-density-lipoprotein (51) 51
biochemistry & molecular biology (50) 50
care and treatment (50) 50
internal medicine (49) 49
plasma (48) 48
cardiology and cardiovascular medicine (47) 47
coronary-artery-disease (47) 47
health aspects (47) 47
apolipoproteins (46) 46
case-control studies (46) 46
genetics & heredity (46) 46
hyperlipoproteinemia type ii - blood (46) 46
lipids - blood (46) 46
risk assessment (46) 46
child (45) 45
safety (45) 45
animals (44) 44
cardiovascular diseases - prevention & control (44) 44
follow-up studies (44) 44
medical colleges (44) 44
mortality (44) 44
triglycerides (44) 44
coronary artery disease (43) 43
cohort studies (42) 42
disease (42) 42
phenotype (41) 41
c-reactive protein (40) 40
simvastatin (40) 40
therapy (40) 40
association (39) 39
atorvastatin calcium (39) 39
statin therapy (39) 39
atorvastatin (38) 38
cardiology (38) 38
heart attacks (37) 37
metaanalysis (37) 37
proportional hazards models (37) 37
coronary artery disease - genetics (36) 36
efficacy (36) 36
studies (36) 36
artery-disease (35) 35
biomarkers - blood (35) 35
cholesterol - blood (35) 35
dose-response relationship, drug (35) 35
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (35) 35
pharmacology & pharmacy (35) 35
pravastatin (35) 35
article (33) 33
coronary artery disease - blood (33) 33
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, p. 774
Journal Article
American Journal of Cardiology, ISSN 0002-9149, 09/2007, Volume 100, Issue 5, pp. 747 - 752
Study) †Conflicts of interest: Dr. LaRosa has served as a consultant to Pfizer, Inc., New York, New York; Merck Whitehouse Station, New Jersey; Bristol-Myers... 
Journal Article
Current Opinion in Lipidology, ISSN 0957-9672, 2014, Volume 25, Issue 6
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article